Conference Recap
Conference Recap
Update on Multiple Sclerosis Comorbidities From CMSC 2021
Key updates from CMSC 2021 on prevalent multiple sclerosis comorbidities including prevalence of hypertension, elevated BMI, depression, and...
Conference Recap
Highlights on DMT Use in Progressive MS From CMSC 2021
New data on DMT use in progressive MS presented at CMSC 2021 — including results from the ACAPELLA and EXPAND trials, and the novel agent ATA188...
Conference Recap
ECTRIMS 2021: Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis
Conference Recap
Multiple sclerosis updates from AAN 2021
Mitzi Joi Williams, MD, highlights important updates in multiple sclerosis stemming from the American...
Conference Recap
Updates in multiple sclerosis symptom management from ACTRIMS 2021
Joseph R. Berger, MD, summarizes abstracts in MS symptom management that were presented at the...
Conference Recap
ACTRIMS 2021: Safety and efficacy of disease-modifying therapies in multiple sclerosis
Mark S. Freedman, MSc, MD, summarizes abstracts on DMTs that were presented at the ACTRIMS Forum...
Conference Recap
ECTRIMS 2020 Highlights: Managing RRMS, Symptoms in the Time of COVID-19
Dr Mark Freedman discusses new data on managing fatigue in patients with RRMS and highlights guidelines for RRMS treatment during the COVID-19...
Conference Recap
Biomarkers for Disease Activity in RRMS Reported at ACTRIMS/ECTRIMS 2020
Dr Tobias Derfuss reviews data indicating that serum neurofilament is a clinically useful biomarker of disease activity in RRMS, as reported at...
Conference Recap
Highlights in Disease-Modifying Therapies From ECTRIMS2020
Dr Patricia Coyle reports on promising image developments presented at ECTRIMS 2020, including research utilizing novel...
Conference Recap
Diagnosis and Monitoring Highlights From ECTRIMS 2020
Dr Patricia Coyle reports on promising image developments presented at ECTRIMS 2020, including research utilizing novel...